Literature DB >> 22080269

Trichomonas vaginalis genital infections: progress and challenges.

Laura H Bachmann1, Marcia M Hobbs, Arlene C Seña, Jack D Sobel, Jane R Schwebke, John N Krieger, R Scott McClelland, Kimberly A Workowski.   

Abstract

Trichomonas vaginalis (TV) infection is the most prevalent curable sexually transmitted infection in the United States and worldwide. Most TV infections are asymptomatic, and the accurate diagnosis of this infection has been limited by lack of sufficiently sensitive and specific diagnostic tests, particularly for men. To provide updates for the 2010 Centers for Disease Control and Prevention's Sexually Transmitted Diseases Treatment Guidelines, a PubMed search was conducted of all TV literature published from 9 January 2004 through 24 September 2008. Approximately 175 pertinent abstracts and articles were reviewed and discussed with national experts. This article describes advances in TV diagnostics which have led to an improved understanding of the epidemiology of this pathogen, as well as potential biologic and epidemiological interactions between TV and human immunodeficiency virus (HIV). New data on treatment outcomes, metronidazole-resistant TV, management of nitroimidazole-allergic patients, frequency of recurrent TV infection following treatment, and screening considerations for TV in certain populations are also presented.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22080269      PMCID: PMC3897282          DOI: 10.1093/cid/cir705

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  68 in total

1.  Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche LightCycler instrument with female self-obtained vaginal swab samples and male urine samples.

Authors:  Andrew Hardick; Justin Hardick; Billie Jo Wood; Charlotte Gaydos
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

2.  High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening.

Authors:  Thomas A Peterman; Lin H Tian; Carol A Metcalf; Catherine L Satterwhite; C Kevin Malotte; Nettie DeAugustine; Sindy M Paul; Helene Cross; Cornelis A Rietmeijer; John M Douglas
Journal:  Ann Intern Med       Date:  2006-10-17       Impact factor: 25.391

3.  The occurrence of vaginal infections among HIV-infected and high-risk HIV-uninfected women: longitudinal findings of the women's interagency HIV study.

Authors:  D Heather Watts; Gayle Springer; Howard Minkoff; Sharon L Hillier; Lisa Jacobson; Michael Moxley; Jessica Justman; Helen Cejtin; Casey O'Connell; Ruth M Greenblatt
Journal:  J Acquir Immune Defic Syndr       Date:  2006-10-01       Impact factor: 3.731

4.  Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens.

Authors:  Barbara Van Der Pol; Colleen S Kraft; James A Williams
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

5.  Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women.

Authors:  Barbara Van Der Pol; Cynthia Kwok; Bosny Pierre-Louis; Anne Rinaldi; Robert A Salata; Pai-Lien Chen; Janneke van de Wijgert; Francis Mmiro; Roy Mugerwa; Tsungai Chipato; Charles S Morrison
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

6.  Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women.

Authors:  Patricia Kissinger; W Evan Secor; Jami S Leichliter; Rebecca A Clark; Norine Schmidt; Erink Curtin; David H Martin
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079

7.  Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics.

Authors:  Donna J Helms; Debra J Mosure; Carol A Metcalf; John M Douglas; C Kevin Malotte; Sindy M Paul; Thomas A Peterman
Journal:  Sex Transm Dis       Date:  2008-05       Impact factor: 2.830

8.  The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004.

Authors:  Madeline Sutton; Maya Sternberg; Emilia H Koumans; Geraldine McQuillan; Stuart Berman; Lauri Markowitz
Journal:  Clin Infect Dis       Date:  2007-10-15       Impact factor: 9.079

9.  HIV, the clustering of sexually transmitted infections, and sex risk among African American women who use drugs.

Authors:  Maureen Miller; Yuyan Liao; Meghan Wagner; Caroline Korves
Journal:  Sex Transm Dis       Date:  2008-07       Impact factor: 2.830

10.  Management of trichomonas vaginalis in women with suspected metronidazole hypersensitivity.

Authors:  Donna J Helms; Debra J Mosure; W Evan Secor; Kimberly A Workowski
Journal:  Am J Obstet Gynecol       Date:  2008-01-25       Impact factor: 8.661

View more
  35 in total

1.  Sexually transmitted infections and HIV: diagnosis and treatment.

Authors:  Kimberly A Workowski
Journal:  Top Antivir Med       Date:  2012 Apr-May

2.  Trichomonas vaginalis and Human Immunodeficiency Virus Coinfection Among Women Under Community Supervision: A Call for Expanded T. vaginalis Screening.

Authors:  Alissa Davis; Anindita Dasgupta; Dawn Goddard-Eckrich; Nabila El-Bassel
Journal:  Sex Transm Dis       Date:  2016-10       Impact factor: 2.830

3.  Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence.

Authors:  Elissa Meites; Eloisa Llata; Jim Braxton; Jane R Schwebke; Kyle T Bernstein; Preeti Pathela; Lenore E Asbel; Roxanne P Kerani; Christie J Mettenbrink; Hillard S Weinstock
Journal:  Sex Transm Dis       Date:  2013-11       Impact factor: 2.830

Review 4.  Single-Dose Compared With Multidose Metronidazole for the Treatment of Trichomoniasis in Women: A Meta-Analysis.

Authors:  Katharine Howe; Patricia J Kissinger
Journal:  Sex Transm Dis       Date:  2017-01       Impact factor: 2.830

5.  Why Does Trichomonas vaginalis Continue to be a "Neglected" Sexually Transmitted Infection?

Authors:  Christina A Muzny
Journal:  Clin Infect Dis       Date:  2018-07-02       Impact factor: 9.079

Review 6.  Strategies for Prevention and Treatment of Trichomonas vaginalis Infections.

Authors:  Kawthar Bouchemal; Christian Bories; Philippe M Loiseau
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

7.  Integrated morphologic and molecular analysis of Trichomonas vaginalis, Mycoplasma hominis, and human papillomavirus using cytologic smear preparations.

Authors:  I Nikas; A Hapfelmeier; M Mollenhauer; D Angermeier; M Bettstetter; R Götz; M Schmidmayr; V Seifert-Klauss; A Muckenhuber; U Schenck; Gregor Weirich
Journal:  Parasitol Res       Date:  2018-03-17       Impact factor: 2.289

8.  Prevalence of urethral Trichomonas vaginalis in black and white men who have sex with men.

Authors:  Colleen F Kelley; Eli S Rosenberg; Brandon M OʼHara; Travis Sanchez; Carlos del Rio; Patrick S Sullivan
Journal:  Sex Transm Dis       Date:  2012-09       Impact factor: 2.830

9.  Hydrogenosome metabolism is the key target for antiparasitic activity of resveratrol against Trichomonas vaginalis.

Authors:  Natalia Mallo; Jesús Lamas; José M Leiro
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

10.  Costs and effectiveness of neonatal male circumcision.

Authors:  Seema Kacker; Kevin D Frick; Charlotte A Gaydos; Aaron A R Tobian
Journal:  Arch Pediatr Adolesc Med       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.